Evidence of reduced coronary artery disease risk for apolipoprotein epsilon2/3 heterozygotes. (Record no. 11963040)

MARC details
000 -LEADER
fixed length control field 00851 a2200217 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250514034627.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field ####s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1879-0828
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1016/s0953-6205(02)00030-4
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Mamotte, Cyril D.S.
245 00 - TITLE STATEMENT
Title Evidence of reduced coronary artery disease risk for apolipoprotein epsilon2/3 heterozygotes.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. European journal of internal medicine
Date of publication, distribution, etc. Jun 2002
300 ## - PHYSICAL DESCRIPTION
Extent 250-255 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Journal Article
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Burke, Valerie
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Taylor, Roger R.
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name van Bockxmeer, Frank M.
773 0# - HOST ITEM ENTRY
Title European journal of internal medicine
Related parts vol. 13
-- no. 4
-- p. 250-255
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1016/s0953-6205(02)00030-4">https://doi.org/10.1016/s0953-6205(02)00030-4</a>
Public note Available from publisher's website

No items available.